Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trilogy International Partners Inc T.TRL.WT.A


Primary Symbol: V.TRL.H

Trilogy International Partners Inc. operates through its subsidiary Trilogy International Partners LLC (Trilogy LLC). Prior to the disposal of its New Zealand and Bolivia operations, Trilogy LLC was a provider of wireless voice and data communications services including local, international long distance and roaming services. Trilogy LLC also provided fixed broadband communications services to residential and enterprise customers in New Zealand and Bolivia. The Company had two reportable segments identified by their geographic regions, New Zealand and Bolivia. Two Degrees Mobile Limited (2degrees) operated in New Zealand and Empresa de Telecomunicaciones NuevaTel (PCS de Bolivia), S.A. (NuevaTel) operated in Bolivia. Both these segments provided a variety of wireless voice and data communications services, including local, international long distance and roaming services. The services were provided to subscribers on both a postpaid and prepaid basis.


TSXV:TRL.H - Post by User

Comment by mercedesmanon Oct 17, 2019 4:50pm
129 Views
Post# 30241682

RE:FYI

RE:FYI
MelnykWasRight wrote:
Natesto manufacturing/dispenser issue has been resolved and is awaiting anticipated Health Canada approval in very near future.  Replacement inventory is ready to go.  More positive news hopefully prior to next quarterly report.  There's light at the end of the tunnel and that light may not be the freight train we were expecting after all. ;)


MelnykWasNotWrong...

If this was the case, shouldn't the company put up a NR to that effect?

Natesto now has tremendous potential but there are 3 - 4 questions plaguing this Company in the very short term.

Have they fixed the ST Manufacturing problem ? 
How much damage was done as a result in the last Qtr ?
Solvency. Can they hang on until Sales pick up substantially, and they become CF positive?
Will the owners dig into their own pockets once again if they become insolvent?

If Urologists are doing their job properly, about 50% of current Testosterone users will/should reconsider the brand they use. There is no saying how many will switch to natesto...as for a good percentage of them, it will be too late to switch anyway.  And or, many may decide to remain brand loyal despite the confirmed advantages now offered by Natesto.
Going forward, it stands to reason that a much higher percentage of NEW Testosterone user perscriptions will be written for Natesto (especially for those men under the age of 50). That is almost a given.  While very positive, higher market share for new users is not the same as an immediate change in market share for existing users.

My assessment is that if both companies can somehow hold on, there is enough potential for Ascerus and AYTU to make a lot of money in the future, ....IF... they can hold on.

MM



<< Previous
Bullboard Posts
Next >>